Real-world analytics company Aetion tops off series B

Aetion Inc. (New York, N.Y.) raised an additional $27 million in its series B round Tuesday to continue building its real-world evidence analytics platform. New investors Sanofi (Euronext:SAN; NASDAQ:SNY), UCB S.A. (Euronext:UCB), McKesson Ventures and Horizon Health Services Inc. participated, as did existing investors NEA, Flare Capital Partners and Lakestar.

Tuesday's untranched funds brings the round's total to $63 million, Aetion said. NEA led the round's first close in April, with participation from Amgen Ventures, Flare Capital Partners, Lakestar and Oxeon Venture...